T1	Participants 513 572	153 patients in pCR following platinum-based intravenous CT
T2	Participants 133 228	patients with a pathologically complete remission after platinum-based intravenous chemotherapy
T3	Participants 826 912	includes 16 patients who were not eligible and 17 patients who had protocol violations
T4	Participants 960 1145	age (median = 55 years), performance status (78% P.S. O), FIGO stage (96% stage III), histology (serous in 66%), grade (2 or 3 in 80%), and residuum before intravenous CT (>1 cm in 40%)
